Vol. 2014 No. 3 (2014)

View Vol. 2014 No. 3 (2014)

Published: 2017-06-30

Editorial

Editors' page

The Editors
- PDF

Lessons from the trials

PARADIGM-HF: Have we achieved a new paradigm in the treatment of heart failure?

Robert O Bonow, Ahmed M ElGuindy
- PDF
NIAMI: Towards the optimization of results in primary PCI

Abdurrazzak Gehani, Jassim Al Suwaidi, Magdi Yacoub
- PDF
RENASICA II: A Mexican acute myocardial infarction registry that highlights the importance of regional registries

Jassim Al Suwaidi
- PDF
HPS2-THRIVE, AIM-HIGH and dal-OUTCOMES: HDL-cholesterol under attack

Mohamed Hassan
- PDF
APOC3: Triglycerides do matter

Mohamed Hassan
- PDF
REVERSE 5-year follow up: CRT impact persists

Mohamed ElMaghawry, Mahmoud Farouk
- PDF
PARIS: A good start for exercise in HFPEF

Ahmed A Elamragy
- PDF

News and views

The Dabigatran debate

Riyaz A Kaba, Farhana Ara, David E Ward, Subo Emanuel
- PDF

Review articles

The role of phosphodiesterase inhibitors in the management of pulmonary vascular diseases

Ghazwan Butrous
- PDF
Endothelial dysfunction and cardiovascular disease

R. Jay Widmer, Amir Lerman
- PDF
Reprogramming for cardiac regeneration

Christophe Michel Raynaud, Faizzan Syed Ahmad, Mona Allouba, Haissam Abou-Saleh, Kathy O Lui, Magdi Yacoub
- PDF
Tissue plasminogen activator-based clot busting: Controlled delivery approaches

Ibrahim M El-Sherbiny, Islam E Elkholi, Magdi H Yacoub
- PDF

Images in cardiology

Antegrade flow in Anomalous Left Coronary Artery from Pulmonary Artery: Clinical implications

Yasser Sedky, Hatem Hosny, Mohamed Donya, Sherin AbdElsalam, Magdi Yacoub
- PDF
Quantitative assessment of right ventricular structure and flow dynamics in pulmonary homograft obstruction

Julien Chapron, Heba Aguib, Stergios Theodoropoulos, Maria Kalantzi, Magdi Yacoub, Ryo Torii
- PDF